Tumor mechanosensing and its therapeutic potential

Area of Science:

• Oncology
• Biophysics
• Cell Biology

Background:

• Cancer mechanics is an emerging hallmark of cancer, influencing tumor development, invasion, and metastasis.
• Tumor mechanosensing describes the mechanical interactions between cancer cells, the extracellular matrix, and stromal cells.
• Mechanoreceptors detect extracellular mechanical cues, activating signaling pathways that promote oncogenic transcription.

Purpose of the Study:

• To highlight the role of tumor mechanosignaling in cancer progression.
• To explore the association between matrix rigidity, mechanotransduction, and anti-cancer drug resistance.
• To identify mechanosensitive molecules as potential therapeutic targets.

Main Methods:

• Review of current literature on cancer mechanics and mechanotransduction.
• Analysis of signaling pathways involved in mechanosensing.
• Correlation of matrix alterations with drug resistance mechanisms.

Main Results:

• Altered matrix rigidity and mechano-induced transcriptional regulators are linked to therapeutic resistance.
• Mechanosensing pathways contribute to cancer initiation, survival, growth, and metastasis.
• Mechanosensitive molecules represent promising targets for novel cancer therapies.

Conclusions:

• Tumor mechanosignaling is a critical factor in cancer progression and drug resistance.
• Targeting mechanosensitive pathways may overcome resistance to existing anti-cancer agents.
• This field offers potential for new combination therapies and targeted treatment strategies.